BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 28583146)

  • 1. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric breast density affects performance of digital screening mammography.
    Wanders JO; Holland K; Veldhuis WB; Mann RM; Pijnappel RM; Peeters PH; van Gils CH; Karssemeijer N
    Breast Cancer Res Treat; 2017 Feb; 162(1):95-103. PubMed ID: 28012087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
    Brand JS; Czene K; Shepherd JA; Leifland K; Heddson B; Sundbom A; Eriksson M; Li J; Humphreys K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1764-72. PubMed ID: 25012995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
    Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
    Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast density and breast cancer-specific survival by detection mode.
    van der Waal D; Verbeek ALM; Broeders MJM
    BMC Cancer; 2018 Apr; 18(1):386. PubMed ID: 29618328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women.
    Sawada T; Akashi S; Nakamura S; Kuwayama T; Enokido K; Yoshida M; Hashimoto R; Ide T; Masuda H; Taruno K; Oyama H; Takamaru T; Kanada Y; Ikeda M; Kosugi N; Sato H; Nakayama S; Ata A; Tonouchi Y; Sakai H; Matsunaga Y; Matsutani A
    Breast Cancer; 2017 Sep; 24(5):708-713. PubMed ID: 28238177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
    Hofvind S; Møller B; Thoresen S; Ursin G
    Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.
    Kerlikowske K; Scott CG; Mahmoudzadeh AP; Ma L; Winham S; Jensen MR; Wu FF; Malkov S; Pankratz VS; Cummings SR; Shepherd JA; Brandt KR; Miglioretti DL; Vachon CM
    Ann Intern Med; 2018 Jun; 168(11):757-765. PubMed ID: 29710124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic density and interval cancers in mammographic screening: Moving towards more personalized screening.
    Larsen M; Lynge E; Lee CI; Lång K; Hofvind S
    Breast; 2023 Jun; 69():306-311. PubMed ID: 36966656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
    Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
    Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Volumetric Breast Density to Quantify the Potential Masking Risk of Mammographic Density.
    Destounis S; Johnston L; Highnam R; Arieno A; Morgan R; Chan A
    AJR Am J Roentgenol; 2017 Jan; 208(1):222-227. PubMed ID: 27824483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening.
    Brandt KR; Scott CG; Ma L; Mahmoudzadeh AP; Jensen MR; Whaley DH; Wu FF; Malkov S; Hruska CB; Norman AD; Heine J; Shepherd J; Pankratz VS; Kerlikowske K; Vachon CM
    Radiology; 2016 Jun; 279(3):710-9. PubMed ID: 26694052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer.
    Duffy SW; Morrish OWE; Allgood PC; Black R; Gillan MGC; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Maroni R; Lim YY; Purushothaman HN; Suaris T; Astley SM; Young KC; Tucker L; Gilbert FJ
    Eur J Cancer; 2018 Jan; 88():48-56. PubMed ID: 29190506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.